about
5-Hydroxytryptamine (serotonin) in the gastrointestinal tractMind the (treatment) gap: a global perspective on current and future strategies for prevention of fragility fractures.Osteoporosis in patients taking selective serotonin reuptake inhibitors: a focus on fracture outcome.Fluoxetine elevates allopregnanolone in female rat brain but inhibits a steroid microsomal dehydrogenase rather than activating an aldo-keto reductase.Effects of Depression and Serotonergic Antidepressants on Bone: Mechanisms and Implications for the Treatment of Depression.Do Selective Serotonin Reuptake Inhibitors (SSRIs) Cause Fractures?The colon: from banal to brilliant.Serotonin and the bone assessmentBreast cancer survivorship: a comprehensive review of long-term medical issues and lifestyle recommendations.Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder.Constitutively Elevated Blood Serotonin Is Associated with Bone Loss and Type 2 Diabetes in Rats.Spinal Bone Texture Assessed by Trabecular Bone Score in Adolescent Girls With Anorexia Nervosa.Anthropometric adjustments are helpful in the interpretation of BMD and BMC Z-scores of pediatric patients with Prader-Willi syndrome.Brains, bones, and aging: psychotropic medications and bone health among older adults.Osteoporosis - a current view of pharmacological prevention and treatmentThe serotonin and the bone assessmentSerotonin-reuptake inhibitors act centrally to cause bone loss in mice by counteracting a local anti-resorptive effect.Clomipramine causes osteoporosis by promoting osteoclastogenesis via E3 ligase Itch, which is prevented by Zoledronic acid.Association between bipolar spectrum disorder and bone health: a meta-analysis and systematic review protocol.The role of the gastrointestinal tract in calcium homeostasis and bone remodeling.Adverse skeletal effects of drugs - beyond Glucocorticoids.Pharmacokinetic and pharmacodynamic interactions between antiepileptics and antidepressants.Management of treatment-resistant depression in children and adolescents.Bone, brain & beyond.Association of Mental Disorders and Related Medication Use With Risk for Major Osteoporotic Fractures.Case-only designs for studying the association of antidepressants and hip or femur fracture.A Review of Adverse Outcomes Associated with Psychoactive Drug Use in Nursing Home Residents with Dementia.Non-conventional features of peripheral serotonin signalling - the gut and beyond.Understanding inconsistency in the results from observational pharmacoepidemiological studies: the case of antidepressant use and risk of hip/femur fractures.Antidepressant use and work-related injuries.Increased Risk of Osteoporosis in Depressive Patients with Erectile Dysfunction: A Cross-sectional Study from MalaysiaCharacteristics of patients who suffer major osteoporotic fractures despite adhering to alendronate treatment: a National Prescription registry study.An ounce of prevention: securing bone health in adolescence.Effect of Exercise and Antidepressants on Skeletal Outcomes in Adolescent Girls With Anorexia Nervosa.The Selective Serotonin Reuptake Inhibitor Fluoxetine Directly Inhibits Osteoblast Differentiation and Mineralization During Fracture Healing in Mice.Pro-inflammatory dietary pattern is associated with fractures in women: an eight-year longitudinal cohort study.Regulation of Bone Metabolism by Serotonin.Patterns of selective serotonin reuptake inhibitor use and risk of falls and fractures in community-dwelling elderly people: the Three-City cohort.Tricyclic antidepressant use and risk of fractures: a meta-analysis of cohort and case-control studies.Hip fracture after first-ever stroke: a population-based study.
P2860
Q26829448-66E5E200-BEFA-4370-914D-8AF7E0CACE6FQ30236007-BADB9F21-37EF-4655-ADC3-A55D05B644F2Q34432269-C27A2CF6-97DB-4F46-B162-E436F7F887A4Q34435307-40407526-2440-402D-9F73-75A548F0B035Q34501008-1405D23F-ADC7-48C7-A2C2-2CB8E55E5D40Q34536565-90636ED9-DFCB-45CE-8AA4-A6C388A4B7F8Q35017883-DBD036AD-183C-48B5-84E7-CC63BFC02F24Q35339741-F3367B86-99E2-4042-A2AC-6576E68158E7Q35490056-9DB781A0-9073-46F4-AB67-5671EE6FA405Q35754726-C56FC6AC-871A-4F56-9A6C-CB2B1FCF9184Q35933172-EF195A11-E5CA-4BF3-A811-43891817DCBCQ36060443-D6E0B628-E5D0-4AE2-9F57-7EB42031B503Q36067847-AC396D87-782F-433D-8F39-4CF39B1DEACAQ36427958-B5E85DCD-6DFE-474A-AEDC-BD805BB6D1ADQ36939677-19B4EC40-1FE7-4D17-845F-1A409296E428Q37050668-4021898A-EEA7-4F6C-B5EE-277438BBDE62Q37317822-96447309-7861-4EBA-AC44-30F53641A3D7Q37618061-E1B0BD7D-FED4-4D87-8B69-DA11A4A44F83Q37681229-8E058CC5-829F-4CD5-9939-73935D1457CCQ38093799-9A0CB25E-198B-435F-BFB2-448A55C6EBB5Q38231316-F5B3AE81-6609-44E4-93E3-EC313B5F05C6Q38246706-E26CB934-C2E3-48A4-BCB5-7B0B85F42F2EQ38247062-FC829613-FABD-4A50-8554-0DA7ACA15A4FQ38378351-265FF159-CE63-47AB-BF1A-CE3F0C59D131Q38830294-FDC29653-6836-4A43-AE08-7928251C4D5FQ38965535-4AA7E19B-7109-4DB9-9650-1BB285EC18A3Q38998448-340BCA38-D0EF-4E0E-81E8-411BDFB08060Q39294424-EB31254C-515D-42A1-BE38-F163CEC791B6Q39869513-CB25DC0E-0239-4A40-AB17-7F898FE91F8BQ40068322-0550A86B-9125-40E2-BAA4-B8341CC1EEABQ41997349-DFD51AB7-E5D3-4A3F-945F-0321C85C49D6Q42673018-5783B819-9E57-413E-9E28-5D7ED8988C07Q42877172-FD71A2F7-5A7C-418D-ADC2-2AF5BDBF0B14Q44289127-69391FD4-97F0-471F-9470-BC76A032B626Q46276238-A0A83CC2-03E0-4D70-8CE0-555B280A6CD8Q47600664-F47CF56A-D1FA-491B-B749-872244AB5D81Q47987551-C4C5F42E-FB03-4F91-A3FA-9BD641291F65Q48051950-826ADD44-3BE6-46E0-866B-31AA995B24A8Q48576448-191EA5B0-0934-44BC-8056-51D9DEBA53BDQ51110519-7EA6F154-72E4-49DE-BF07-D4F3C69F31E4
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Antidepressant medications and osteoporosis.
@en
type
label
Antidepressant medications and osteoporosis.
@en
prefLabel
Antidepressant medications and osteoporosis.
@en
P2093
P50
P1433
P1476
Antidepressant medications and osteoporosis
@en
P2093
G Karsenty
J Compston
J D Adachi
J-Y Reginster
M L Brandi
P Vestergaard
P304
P356
10.1016/J.BONE.2012.05.018
P577
2012-05-30T00:00:00Z